MYOSLID is a novel human VSMC-selective lncRNA that amplifies the VSMC differentiation program.
No takes yet. Share an insight, caveat, or question.
No immediate clinical implications; extends VSMC regulation mechanisms in animals and leaves open human therapeutic translation.
Zhao et al. (2016) studied this question.
Synapse has enriched 4 closely related papers on similar clinical questions. Consider them for comparative context: